The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...

South Australia will ban advertisements of ham sandwiches on public transport in a bid to tackle childhood and adult obesity.

Metformin may reduce knee pain in overweight patients with osteoarthritis, offering a low-cost alternative to early knee ...

Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Fractyl Health, Inc.’s GUTS share price has dipped by 5.08%, which has investors questioning if this is right time to buy.

In the first part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...

Chocolate milk is both healthy and unhealthy. It contains essential nutrients, such as calcium and vitamin D, but it's also ...

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the ...